0001209191-20-055435.txt : 20201020 0001209191-20-055435.hdr.sgml : 20201020 20201020204832 ACCESSION NUMBER: 0001209191-20-055435 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201016 FILED AS OF DATE: 20201020 DATE AS OF CHANGE: 20201020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beckman Daniella CENTRAL INDEX KEY: 0001513422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39612 FILM NUMBER: 201249389 MAIL ADDRESS: STREET 1: C/O IDENIX PHARMACEUTICALS, INC. STREET 2: ONE KENDALL SQUARE, BLDG. 1400 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 5:01 Acquisition Corp. CENTRAL INDEX KEY: 0001823465 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 852790755 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 SECOND STREET, SUITE 350 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 415-993-8570 MAIL ADDRESS: STREET 1: 501 SECOND STREET, SUITE 350 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-16 0 0001823465 5:01 Acquisition Corp. FVAM 0001513422 Beckman Daniella C/O 5:01 ACQUISITION CORP. 501 SECOND STREET, SUITE 350 SAN FRANCISCO CA 94107 1 0 0 0 Class B Common Stock 2020-10-16 4 J 0 30000 0.00 A Class A Common Stock 30000 30000 D The shares of Class B common stock are automatically convertible into the issuer's shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, and have no expiration date. The shares of Class B common stock are subject to forfeiture under certain circumstances relating to the Reporting Person's service on the issuer's Board of Directors. In connection with the issuer's initial public offering and the Reporting Person's appointment to the issuer's Board of Directors, 5:01 Acquisition LLC transferred 30,000 shares of Class B common stock to the Reporting Person. /s/ Nathan Jeffries, Attorney-in-Fact 2020-10-20